These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. New abortive agents for the treatment of migraine. Potrebic S; Raskin NH Adv Intern Med; 2001; 46():1-29. PubMed ID: 11147249 [No Abstract] [Full Text] [Related]
8. Triptans to the rescue: effective therapy for migraine headaches in the workplace. Bartleson JD Mayo Clin Proc; 2000 Aug; 75(8):780-1. PubMed ID: 10943229 [No Abstract] [Full Text] [Related]
9. Acute management of migraine: triptans and beyond. Diener HC; Limmroth V Curr Opin Neurol; 1999 Jun; 12(3):261-7. PubMed ID: 10499171 [TBL] [Abstract][Full Text] [Related]
13. Looking forward: the expanding utility of sumatriptan and naratriptan. Cady R Cephalalgia; 2001; 21 Suppl 1():35-8. PubMed ID: 11678821 [No Abstract] [Full Text] [Related]
14. What matters is not the differences between triptans, but the differences between patients. Saper JR Arch Neurol; 2001 Sep; 58(9):1481-2. PubMed ID: 11559323 [No Abstract] [Full Text] [Related]
15. Comparative aspects of triptans in treating migraine. Adelman JU; Lewit EJ Clin Cornerstone; 2001; 4(3):53-64. PubMed ID: 12739316 [TBL] [Abstract][Full Text] [Related]
16. New "triptans" and other drugs for migraine. Med Lett Drugs Ther; 1998 Oct; 40(1037):97-100. PubMed ID: 9793036 [No Abstract] [Full Text] [Related]
17. Building on the sumatriptan experience: the development of naratriptan. Connor HE Cephalalgia; 2001; 21 Suppl 1():32-4. PubMed ID: 11678820 [No Abstract] [Full Text] [Related]
18. Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans). Marcus DA Arch Neurol; 2001 Jul; 58(7):1056-8. PubMed ID: 11448293 [TBL] [Abstract][Full Text] [Related]
19. Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew. Goldstein D Cephalalgia; 1999 Jun; 19(5):536-7. PubMed ID: 10403072 [No Abstract] [Full Text] [Related]